Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Clinical trial NCT02872116 · COMPLETED

Trial details

NCT number: NCT02872116
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Cancer Gastroesophageal Junction Cancer Esophageal Adenocarcinoma

Start date: 2016-10-12
Primary completion: 2020-05-27
Enrollment: 2031

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.